R. Collins

Surgery · The Lancet · 2000–2021

A researcher in the Science corpus: 49 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom R. Collins trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. AndrewJ. S. Coats
  2. J. Armitage
  3. M. Law

Who trusts R. Collins overall

  1. Massimo F. Piepoli
  2. V. Basevi
  3. I. Graham
  4. S. Grundy
  5. Euan A. Ashley
  6. E. Sanderson
  7. T. Ivanova
  8. George Davey Smith
  9. J. Armitage
  10. Peter Libby

Papers from R. Collins's perspective

Ordered by how strongly the researchers R. Collins trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (Journal of the American Pharmacists Association)
  2. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (The Lancet)
  3. When are randomised trials unnecessary? Picking signal from noise (British medical journal)
  4. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial… (European Heart Journal)
  5. Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study (Cardiovascular Drugs and Therapy)
  6. Evaluating non-randomised intervention studies. (Health Technology Assessment)
  7. Statin safety: a systematic review. (American Journal of Cardiology)
  8. Adjusting for non-compliance and contamination in randomized clinical trials.
  9. Cardiovascular Benefits and Diabetes Risks of Statin Therapy in Primary Prevention (The Lancet)
  10. Bias and causal associations in observational research.

Their papers